Bioventus (BVS) Long-Term Investments (2020 - 2026)
Bioventus' (BVS) quarterly Long-Term Investments came in at $2.1 million in Q1 2026, up 19.7% YoY from $1.8 million in Q1 2025, and down 8.33% on a QoQ basis from $2.3 million in Q4 2025.
Bioventus (BVS) Long-Term Investments (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Long-Term Investments data on file, last reported at $2.1 million in Q1 2026.
- Quarterly Long-Term Investments rose 19.7% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 19.7% YoY) and the FY2025 annual result came in at $2.3 million, up 21.19% from the prior year.
- Long-Term Investments eased to $2.1 million in Q1 2026, from $2.3 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $78.5 million in Q3 2022 to a low of $1.7 million in Q2 2025.
- A 5-year average of $9.5 million and a median of $2.6 million in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments jumped 302.84% — and 2023, when it plunged 91.67%.
- Tracing BVS's Long-Term Investments over 5 years: stood at $2.6 million in 2022, then increased by 19.84% to $3.1 million in 2023, then plunged by 39.76% to $1.9 million in 2024, then climbed by 21.19% to $2.3 million in 2025, then slipped by 8.33% to $2.1 million in 2026.
- The last three Long-Term Investments figures came in at $2.1 million (Q1 2026), $2.3 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 2.25 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 244.10 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 175.52 Mn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | - |
| 10 | Bioventus | 967.14 Mn | 937.68 Mn | 105.67 Mn | 3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 3.51 Mn |
| Mar 28, 2026 | 2.10 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 27, 2025 | 2.27 Mn |
| Jun 28, 2025 | 1.69 Mn |
| Mar 29, 2025 | 1.76 Mn |
| Dec 31, 2024 | 1.89 Mn |
| Sep 28, 2024 | 1.93 Mn |
| Jun 29, 2024 | 2.09 Mn |
| Mar 30, 2024 | 3.21 Mn |
| Dec 31, 2023 | 3.14 Mn |
| Sep 30, 2023 | 6.86 Mn |
| Jul 1, 2023 | 6.54 Mn |
| Apr 1, 2023 | 2.62 Mn |
| Dec 31, 2022 | 2.62 Mn |
| Oct 1, 2022 | 13.03 Mn |
| Jul 2, 2022 | 78.49 Mn |
| Apr 2, 2022 | 28.81 Mn |
| Dec 31, 2021 | 16.77 Mn |
| Oct 2, 2021 | 29.32 Mn |